,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,166539,6,2,,103330346,70775,Unspecified,,,100.0,IC50,Inhibitory activity against release of beta-hexosaminidase from RBL-2H3 cells,Confirmatory,12951092.0,
1,166551,3,4,,103330346,70775,Unspecified,,,,,Percentage inhibition against release of beta-hexosaminidase from RBL-2H3 cells at 100 uM from control,Other,12951092.0,
2,248765,9,1,,103330346,70775,Active,,,15.0,IC50,Inhibitory concentration of compound on nitric oxide (NO) production in lipopolysaccharide activated mouse peritoneal macrophages,Confirmatory,15780639.0,
3,323186,3,4,,103330346,70775,Unspecified,,,,,Protection against 30 mins photoirradiation-induced lipid peroxidation damage in rat liver mitochondria assessed as prevention of TBARS formation at 30 uM,Other,18207412.0,
4,323187,3,4,,103330346,70775,Unspecified,,,,,Protection against 30 mins photoirradiation-induced lipid peroxidation damage in rat liver mitochondria assessed as prevention of TBARS formation at 60 uM,Other,18207412.0,
5,323188,3,4,,103330346,70775,Unspecified,,,,,Protection against 30 mins photoirradiation-induced lipid peroxidation damage in rat liver mitochondria assessed as prevention of TBARS formation at 180 uM,Other,18207412.0,
6,323189,3,4,,103330346,70775,Unspecified,,,,,Protection against 30 mins photoirradiation-induced damage in rat liver mitochondria assessed as reduction of lipid hydroperoxide formation at 180 uM,Other,18207412.0,
7,323195,3,5,,103330346,70775,Unspecified,,,,,Cytotoxicity against mouse L929 cells assessed as survival at 5 uM after 20 hrs by MTT method relative to control,Other,18207412.0,
8,323196,3,5,,103330346,70775,Unspecified,,,,,Cytotoxicity against mouse L929 cells assessed as survival at 10 uM after 20 hrs by MTT method relative to control,Other,18207412.0,
9,323197,3,5,,103330346,70775,Unspecified,,,,,Cytotoxicity against mouse L929 cells assessed as survival at 20 uM after 20 hrs by MTT method relative to control,Other,18207412.0,
10,323200,3,4,,103330346,70775,Unspecified,,,,,Prevention of 15 mins photoirradiation-induced damage in mouse L929 cells assessed as survival at 9 uM by MTT assay,Other,18207412.0,
11,323204,3,5,,103330346,70775,Unspecified,,,,,Prevention of 5 mins photoirradiation-induced damage in mouse L929 cells assessed as survival at 10 uM by MTT assay,Other,18207412.0,
12,323205,3,5,,103330346,70775,Unspecified,,,,,Prevention of 10 mins photoirradiation-induced damage in mouse L929 cells assessed as survival at 10 uM by MTT assay,Other,18207412.0,
13,323206,3,5,,103330346,70775,Unspecified,,,,,Prevention of 15 mins photoirradiation-induced damage in mouse L929 cells assessed as survival at 10 uM by MTT assay,Other,18207412.0,
14,323207,3,5,,103330346,70775,Unspecified,,,,,Prevention of 5 mins photoirradiation-induced damage in mouse L929 cells assessed as survival at 5 uM by MTT assay,Other,18207412.0,
15,323208,3,5,,103330346,70775,Unspecified,,,,,Prevention of 10 mins photoirradiation-induced damage in mouse L929 cells assessed as survival at 5 uM by MTT assay,Other,18207412.0,
16,323209,3,5,,103330346,70775,Unspecified,,,,,Prevention of 15 mins photoirradiation-induced damage in mouse L929 cells assessed as survival at 5 uM by MTT assay,Other,18207412.0,
17,334211,3,4,,103330346,70775,Unspecified,,,,,Cytotoxicity against human NUGC cells at 50 uM,Other,12608845.0,
18,515754,1,4,,103330346,70775,Inactive,,,,,Cytotoxicity against human MCF7 cells at 100 uM after 72 hrs by MTT assay,Other,20805034.0,
19,543406,5,2,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans ATCC 25175 by turbidimetric analysis,Other,18573934.0,
20,543407,5,2,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Enterococcus faecium ATCC 8042 by turbidimetric analysis,Other,18573934.0,
21,543586,5,2,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Enterococcus faecalis ATCC 29212 by turbidimetric analysis,Other,18573934.0,
22,543587,5,2,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Streptococcus sanguis ATCC 10556 by turbidimetric analysis,Other,18573934.0,
23,543588,5,2,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Actinomyces viscosus ATCC 15987 by turbidimetric analysis,Other,18573934.0,
24,543589,5,2,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Haemophilus actinomycetemcomitans ATCC 29522 by turbidimetric analysis,Other,18573934.0,
25,543590,5,2,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Prevotella intermedia ATCC 25611 by turbidimetric analysis,Other,18573934.0,
26,543591,5,2,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Fusobacterium nucleatum ATCC 10953 by turbidimetric analysis,Other,18573934.0,
27,543592,5,2,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 by turbidimetric analysis,Other,18573934.0,
28,543593,4,1,,103330346,70775,Unspecified,,,,,Bactericidal activity against Streptococcus mutans ATCC 25175 after 24 hrs by turbidimetric analysis,Other,18573934.0,
29,543594,4,1,,103330346,70775,Unspecified,,,,,Bactericidal activity against Enterococcus faecium ATCC 8042 after 24 hrs by turbidimetric analysis,Other,18573934.0,
30,543595,4,1,,103330346,70775,Unspecified,,,,,Bactericidal activity against Enterococcus faecalis ATCC 29212 after 24 hrs by turbidimetric analysis,Other,18573934.0,
31,543596,4,1,,103330346,70775,Unspecified,,,,,Bactericidal activity against Streptococcus sanguis ATCC 10556 after 24 hrs by turbidimetric analysis,Other,18573934.0,
32,543597,4,1,,103330346,70775,Unspecified,,,,,Bactericidal activity against Actinomyces viscosus ATCC 15987 after 24 hrs by turbidimetric analysis,Other,18573934.0,
33,543598,4,1,,103330346,70775,Unspecified,,,,,Bactericidal activity against Haemophilus actinomycetemcomitans ATCC 29522 after 24 hrs by turbidimetric analysis,Other,18573934.0,
34,543599,4,1,,103330346,70775,Unspecified,,,,,Bactericidal activity against Prevotella intermedia ATCC 25611 after 24 hrs by turbidimetric analysis,Other,18573934.0,
35,543600,4,1,,103330346,70775,Unspecified,,,,,Bactericidal activity against Fusobacterium nucleatum ATCC 10953 after 24 hrs by turbidimetric analysis,Other,18573934.0,
36,543601,4,1,,103330346,70775,Unspecified,,,,,Bactericidal activity against Porphyromonas gingivalis ATCC 33277 after 24 hrs by turbidimetric analysis,Other,18573934.0,
37,543602,2,3,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as log reduction in bacterial growth at 250 ug/ml measured at 10 hrs by time kill analysis,Other,18573934.0,
38,543603,2,4,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as reduction in bacterial growth at 2 times MIC measured at 8 hrs by time kill analysis,Other,18573934.0,
39,543604,2,4,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as reduction in bacterial growth at 4 times MIC measured at 4 hrs by time kill analysis,Other,18573934.0,
40,543605,2,3,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans ATCC 25175 after 12 hrs by time kill analysis,Other,18573934.0,
41,543606,2,3,,103330346,70775,Active,,,,,Antimicrobial activity against adherent cells of Streptococcus mutans ATCC 25175 at 1000 ug/ml,Other,18573934.0,
42,543607,3,3,,103330346,70775,Active,,,,,Antimicrobial activity against adherent cells of Streptococcus mutans ATCC 25175 assessed as inhibition of water-insoluble glucan synthesis at 1000 ug/ml in presence of sucrose,Other,18573934.0,
43,543608,2,3,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans ATCC 25175 at 125 to 500 ug/ml by time kill analysis,Other,18573934.0,
44,543609,2,4,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as post antibiotic effect at 250 ug/ml,Other,18573934.0,
45,543610,2,4,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as post antibiotic effect at 2 times MIC,Other,18573934.0,
46,543611,2,4,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Actinomyces viscosus ATCC 15987 assessed as post antibiotic effect at 250 ug/ml,Other,18573934.0,
47,543612,2,4,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Actinomyces viscosus ATCC 15987 assessed as post antibiotic effect at 2 times MIC,Other,18573934.0,
48,543613,5,2,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as inhibition of biofilm formation after 24 hrs by crystal violet staining,Other,18573934.0,
49,543614,5,2,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Actinomyces viscosus ATCC 15987 assessed as inhibition of biofilm formation after 24 hrs by crystal violet staining,Other,18573934.0,
50,543615,5,2,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as eradication of preformed biofilm after 24 hrs by crystal violet staining,Other,18573934.0,
51,543616,5,2,,103330346,70775,Unspecified,,,,,Antimicrobial activity against Actinomyces viscosus ATCC 15987 assessed as eradication of preformed biofilm after 24 hrs by crystal violet staining,Other,18573934.0,
52,543617,2,3,,103330346,70775,Active,,,,,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as increase in membrane permeability at 1000 ug/ml after 30 mins by propidium iodide staining-based flow cytometry,Other,18573934.0,
53,543618,2,3,,103330346,70775,Active,,,,,Antimicrobial activity against Actinomyces viscosus ATCC 15987 assessed as increase in membrane permeability at 1000 ug/ml after 30 mins by propidium iodide staining-based flow cytometry,Other,18573934.0,
54,543619,1,5,,103330346,70775,Unspecified,,,,,Antioxidant activity in rat liver microsomes assessed as reduction in lipid peroxidation at 10 to 100 ug/ml by thiobarbituric acid assay,Other,18573934.0,
55,543620,3,3,,103330346,70775,Active,,,,,Antiinflammatory activity against human neutrophils assessed as inhibition of LPS-stimulated TNFalpha production at 5 ug/ml after 3 hrs by FACS analysis,Other,18573934.0,
56,543621,3,3,,103330346,70775,Active,,,,,Antiinflammatory activity against human neutrophils assessed as inhibition of LPS-stimulated TNFalpha production at 2.5 ug/ml after 3 hrs by FACS analysis,Other,18573934.0,
57,543622,3,3,,103330346,70775,Active,,,,,Antiinflammatory activity against human neutrophils assessed as inhibition of LPS-stimulated TNFalpha production at 10 ug/ml after 3 hrs by FACS analysis,Other,18573934.0,
58,543623,2,3,,103330346,70775,Unspecified,,,,,Cytotoxicity against human neutrophils at 2.5 to 10 ug/ml after 3 hrs by MTT assay,Other,18573934.0,
59,543625,1,3,,103330346,70775,Unspecified,,,,,Toxicity in healthy human assessed as occurrence of after taste,Other,18573934.0,
60,543626,1,3,,103330346,70775,Unspecified,,,,,Toxicity in healthy human assessed as occurrence of tingling sensation,Other,18573934.0,
61,1075968,1,3,,103330346,70775,Unspecified,,,83.0,IC50,Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay,Confirmatory,24508612.0,
62,1075969,1,2,,103330346,70775,Unspecified,,,55.0,IC50,Cytotoxicity against human PC3 cells assessed as growth inhibition after 48 hrs by MTT assay,Confirmatory,24508612.0,
63,1110759,3,1,,103330346,70775,Unspecified,,,,,Nematocidal activity against Caenorhabditis elegans assessed as mortality,Other,12147760.0,
64,1187905,1,2,,103330346,70775,Unspecified,317373572.0,2548.0,,,Inhibition of alpha-glucosidase (unknown origin) using 3 mM p-NPG solution at 50 uM relative to control,Other,25127165.0,
65,1187906,1,2,,103330346,70775,Active,,,,,Antioxidant activity assessed as trolox equivalent of AAPH radical scavenging activity at 1 uM after 2 mins by ORAC-RCoo assay,Other,25127165.0,
66,1187907,1,2,,103330346,70775,Active,,,,,Antioxidant activity assessed as trolox equivalent of AAPH radical scavenging activity at 10 uM after 2 mins by ORAC-RCoo assay,Other,25127165.0,
67,1187908,1,1,,103330346,70775,Active,,,,,Antioxidant activity assessed as copper(I)ion reduction power at 1 uM after 1 hr by cupric ion reducing antioxidant capacity assay,Other,25127165.0,
68,1187909,1,1,,103330346,70775,Active,,,,,Antioxidant activity assessed as copper(I)ion reduction power at 10 uM after 1 hr by cupric ion reducing antioxidant capacity assay,Other,25127165.0,
69,1187910,1,1,,103330346,70775,Unspecified,,,,,Metal chelating activity of the compound assessed as Cu2+ chelating activity at 10 uM by fluorescence assay relative to control,Other,25127165.0,
70,1196408,1,1,,103330346,70775,Unspecified,,,,,Reduction in mitochondrial membrane potential in human HL60 cells at 5 uM after 24 hrs by Rh-123-staining based flow cytometry (Rvb = 7%),Other,25559204.0,
71,1196410,1,1,,103330346,70775,Unspecified,,,,,Growth inhibition of human HL60 cells at 30 uM after 72 hrs by MTT assay,Other,25559204.0,
72,1196411,1,1,,103330346,70775,Unspecified,,,,,Growth inhibition of human HL60 cells at 50 uM after 72 hrs by MTT assay,Other,25559204.0,
73,1196412,1,1,,103330346,70775,Unspecified,,,,,Growth inhibition of human MIAPaCa2 cells at 30 uM after 72 hrs by MTT assay,Other,25559204.0,
74,1196413,1,1,,103330346,70775,Unspecified,,,,,Growth inhibition of human MIAPaCa2 cells at 50 uM after 72 hrs by MTT assay,Other,25559204.0,
75,1196414,1,1,,103330346,70775,Unspecified,,,,,Growth inhibition of human MCF7 cells at 30 uM after 72 hrs by MTT assay,Other,25559204.0,
76,1196415,1,1,,103330346,70775,Unspecified,,,,,Growth inhibition of human MCF7 cells at 50 uM after 72 hrs by MTT assay,Other,25559204.0,
77,1196416,1,1,,103330346,70775,Unspecified,,,,,Growth inhibition of human HepG2 cells at 30 uM after 72 hrs by MTT assay,Other,25559204.0,
78,1196417,1,1,,103330346,70775,Unspecified,,,,,Growth inhibition of human HepG2 cells at 50 uM after 72 hrs by MTT assay,Other,25559204.0,
79,1196418,1,1,,103330346,70775,Unspecified,,,,,Growth inhibition of human SK-N-SH cells at 30 uM after 72 hrs by MTT assay,Other,25559204.0,
80,1196419,1,1,,103330346,70775,Unspecified,,,,,Growth inhibition of human SK-N-SH cells at 50 uM after 72 hrs by MTT assay,Other,25559204.0,
81,1196420,1,1,,103330346,70775,Active,,,3.0,IC50,Growth inhibition of human HL60 cells after 72 hrs by MTT assay,Confirmatory,25559204.0,
82,1196421,1,1,,103330346,70775,Unspecified,,,30.0,IC50,Growth inhibition of human MIAPaCa2 cells after 72 hrs by MTT assay,Confirmatory,25559204.0,
83,1196422,1,1,,103330346,70775,Unspecified,,,30.0,IC50,Growth inhibition of human MCF7 cells after 72 hrs by MTT assay,Confirmatory,25559204.0,
84,1196423,1,1,,103330346,70775,Unspecified,,,30.0,IC50,Growth inhibition of human HepG2 cells after 72 hrs by MTT assay,Confirmatory,25559204.0,
85,1196424,1,1,,103330346,70775,Unspecified,,,30.0,IC50,Growth inhibition of human SK-N-SH cells after 72 hrs by MTT assay,Confirmatory,25559204.0,
86,1196425,1,1,,103330346,70775,Unspecified,,,50.0,IC50,Growth inhibition of human HL60 cells after 24 hrs by MTT assay,Confirmatory,25559204.0,
87,1196426,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as apoptotic cells at 5 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 3%),Other,25559204.0,
88,1196427,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as accumulation at G1 phase at 5 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 36%),Other,25559204.0,
89,1196428,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as accumulation at S phase at 5 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 63%),Other,25559204.0,
90,1196429,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as accumulation at G2 phase at 5 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 1%),Other,25559204.0,
91,1196430,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as apoptotic cells at 10 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 3%),Other,25559204.0,
92,1196431,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as accumulation at G1 phase at 10 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 36%),Other,25559204.0,
93,1196432,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as accumulation at S phase at 10 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 63%),Other,25559204.0,
94,1196433,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as accumulation at G2 phase at 10 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 1%),Other,25559204.0,
95,1196434,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as apoptotic cells at 15 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 3%),Other,25559204.0,
96,1196435,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as accumulation at G1 phase at 15 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 36%),Other,25559204.0,
97,1196436,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as accumulation at S phase at 15 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 63%),Other,25559204.0,
98,1196437,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as accumulation at G2 phase at 15 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 63%),Other,25559204.0,
99,1196438,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as apoptotic cells at 20 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 3%),Other,25559204.0,
100,1196439,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as accumulation at G1 phase at 20 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 36%),Other,25559204.0,
101,1196440,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as accumulation at S phase at 20 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 36%),Other,25559204.0,
102,1196441,1,1,,103330346,70775,Unspecified,,,,,Cell cycle arrest in human HL60 cells assessed as accumulation at G2 phase at 20 uM after 24 hrs by propidium iodide-staining based flow cytometry (Rvb = 36%),Other,25559204.0,
103,1196442,1,1,,103330346,70775,Unspecified,,,,,Reduction in mitochondrial membrane potential in human HL60 cells at 10 uM after 24 hrs by Rh-123-staining based flow cytometry (Rvb = 7%),Other,25559204.0,
104,1196443,1,1,,103330346,70775,Unspecified,,,,,Reduction in mitochondrial membrane potential in human HL60 cells at 15 uM after 24 hrs by Rh-123-staining based flow cytometry (Rvb = 7%),Other,25559204.0,
105,1196444,1,1,,103330346,70775,Unspecified,,,,,Reduction in mitochondrial membrane potential in human HL60 cells at 20 uM after 24 hrs by Rh-123-staining based flow cytometry (Rvb = 7%),Other,25559204.0,
106,1196445,1,1,,103330346,70775,Active,,,,,Induction of apoptosis in human HL60 cells assessed as apoptotic bodies formation at 5 to 20 uM after 24 hrs by Hoechst 33342-staining based fluorescence microscopy,Other,25559204.0,
107,1196446,1,1,,103330346,70775,Active,,,,,Induction of apoptosis in human HL60 cells assessed as effect on morphology at 5 to 20 uM after 24 hrs by phase-contrast microscopy,Other,25559204.0,
108,1259407,1,1,,363899474,70775,Inactive,,,,,CCRIS mutagenicity studies,Other,,
